BRUSSELS, Belgium--(BUSINESS WIRE)--Pfizer welcomes the 1st European Parliamentary symposium on pharmaceuticals “Putting an end to drug counter-feiting”, which convened European policy makers, regulators and specialists on counterfeiting and medicines trading in the European Parliament today.
